Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 3Phase NA 2Phase 2 1

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 754OTHER 379NIH 68NETWORK 14OTHER_GOV 3FED 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Neoplasm Metastasis 2Motor Activity 2Thoracic Neoplasms 1Stroke 1Prostatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neurofibromatosis 2 1Neoplasms by Site 1Neoplasms 1Myasthenia Gravis 1Melanoma 1Lymphoproliferative Disorders 1Lung Diseases 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Diabetes Mellitus 1Coronary Disease 1Condylomata Acuminata 1Colorectal Neoplasms 1Carcinoma, Bronchogenic 1Breast Neoplasms, Male 1

Interventions

pembrolizumab 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × FED × Carcinoma, Non-Small-Cell Lung × Clear all
NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

VA Ann Arbor Healthcare System

Phase 1 Recruiting
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01574222 2018-01-18

VTNSCLC

VA Office of Research and Development

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Thoracic Neoplasms

NCT00108186 2014-10-29

Celecoxib Treatment for Lung Cancer

VA Office of Research and Development

Phase 1 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡